Literature DB >> 15238435

Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains.

Hans-Joachim Lüth1, Vera Ogunlade, Björn Kuhla, Rosemarie Kientsch-Engel, Peter Stahl, Julie Webster, Thomas Arendt, Gerald Münch.   

Abstract

In this immunohistochemical study, the age- and stage-dependent accumulation of advanced glycation end-products (AGEs) in Alzheimer's disease (AD) and their relation to the formation of neurofibrillary tangles and neuronal cell death was investigated. For this purpose, the distribution of AGEs in neurons and glia was analyzed in the auditory association area of superior temporal gyrus (Brodmann area 22) of young and old non-demented controls and compared with early- and late-stage AD. A possible co-localization of AGEs with typical hallmarks of AD, such as hyperphosphorylated tau (as a marker for disturbed kinase/phosphatase activity), nNOS (as a marker for nitroxidative stress) and caspase-3 (as a marker of apoptotic cell death), was also investigated. Our results show that the percentage of AGE-positive neurons (and astroglia) increase both with age and, in AD patients, with the progression of the disease (Braak stages). Interestingly, nearly all if those neurons which show diffuse cytosolic AGE immunoreactivity also contain hyperphosphoryated tau, suggesting a link between AGE accumulation and the formation of early neurofibrillary tangles. Many, but not all, neurons show a co-localization of AGEs with other markers of neurodegeneration, such as nNOS and caspase-3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15238435     DOI: 10.1093/cercor/bhh123

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  57 in total

1.  PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease.

Authors:  Marwan N Sabbagh; Albert Agro; Joanne Bell; Paul S Aisen; Edward Schweizer; Douglas Galasko
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jul-Sep       Impact factor: 2.703

2.  Glyoxal detoxification in Escherichia coli K-12 by NADPH dependent aldo-keto reductases.

Authors:  Changhan Lee; Insook Kim; Chankyu Park
Journal:  J Microbiol       Date:  2013-08-30       Impact factor: 3.422

Review 3.  Human cerebral neuropathology of Type 2 diabetes mellitus.

Authors:  Peter T Nelson; Charles D Smith; Erin A Abner; Frederick A Schmitt; Stephen W Scheff; Gregory J Davis; Jeffrey N Keller; Gregory A Jicha; Daron Davis; Wang Wang-Xia; Adria Hartman; Douglas G Katz; William R Markesbery
Journal:  Biochim Biophys Acta       Date:  2008-08-22

Review 4.  Role of RAGE in Alzheimer's Disease.

Authors:  Zhiyou Cai; Nannuan Liu; Chuanling Wang; Biyong Qin; Yingjun Zhou; Ming Xiao; Liying Chang; Liang-Jun Yan; Bin Zhao
Journal:  Cell Mol Neurobiol       Date:  2015-07-15       Impact factor: 5.046

5.  Differences Between Tg2576 and Wild Type Mice in the NMDA Receptor-Nitric Oxide Pathway After Prolonged Application of a Diet High in Advanced Glycation End Products.

Authors:  Zdena Kristofikova; Jan Ricny; Jana Sirova; Daniela Ripova; Irit Lubitz; Michal Schnaider-Beeri
Journal:  Neurochem Res       Date:  2015-07-19       Impact factor: 3.996

6.  Methylglyoxal alters glucose metabolism and increases AGEs content in C6 glioma cells.

Authors:  Fernanda Hansen; Daniela Fraga de Souza; Simone da Luz Silveira; Ana Lúcia Hoefel; Júlia Bijoldo Fontoura; Ana Carolina Tramontina; Larissa Daniele Bobermin; Marina Concli Leite; Marcos Luiz Santos Perry; Carlos Alberto Gonçalves
Journal:  Metab Brain Dis       Date:  2012-07-18       Impact factor: 3.584

Review 7.  Glycation vs. glycosylation: a tale of two different chemistries and biology in Alzheimer's disease.

Authors:  Naoyuki Taniguchi; Motoko Takahashi; Yasuhiko Kizuka; Shinobu Kitazume; Vladimir V Shuvaev; Tomomi Ookawara; Akiko Furuta
Journal:  Glycoconj J       Date:  2016-06-21       Impact factor: 2.916

8.  Pro-inflammatory effects of early non-enzymatic glycated proteins in human mesothelial cells vary with cell donor's age.

Authors:  L Rodríguez-Mañas; C Sánchez-Rodríguez; S Vallejo; M El-Assar; C Peiró; V Azcutia; N Matesanz; C F Sánchez-Ferrer; J Nevado
Journal:  Br J Pharmacol       Date:  2006-10-30       Impact factor: 8.739

Review 9.  Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer's disease pathology.

Authors:  Thomas Arendt; Jens Stieler; Max Holzer
Journal:  J Neural Transm (Vienna)       Date:  2014-12-06       Impact factor: 3.575

10.  Self-vaccination by methamphetamine glycation products chemically links chronic drug abuse and cardiovascular disease.

Authors:  Jennifer Treweek; Sunmee Wee; George F Koob; Tobin J Dickerson; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.